Clinical Trials on Manual Lymphatic Drainage in Canada

Total 4551 results

Lions Gate Hospital
University of British Columbia; Vancouver Coastal Health Research Institute

Completed

Ketofol vs Propofol for Emergency Department Procedural Sedation and Analgesia

Emergency Department Procedural Sedation | Fracture Reduction | Abscess Incision and Drainage | Electrical Cardioversion

Canada
Lance Armstrong Foundation

Unknown

Healthy Exercise for Lymphoma Patients (HELP) (HELP)

Lymphoma

Canada
McGill University
McGill University Health Centre/Research Institute of the McGill University... and other collaborators

Completed

Feasibility, Acceptability, and Preliminary Effects of Lymfit (Lymfit)

Lymphoma | Cancer Survivors

Canada
Ottawa Hospital Research Institute

Terminated

LYMPHA: Eliminating the Burden of Lymphedema in Patients Requiring Nodal Dissection

Lymph Node Disease

Canada
University Health Network, Toronto
Hoffmann-La Roche; Ozmosis Research Inc.

Completed

Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin's

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Cardiac Sarcoidosis Response To Steroids Trial (CASTOR)

Sarcoidosis | Cardiac Sarcoidosis

Canada
McGill University
McGill University Health Centre/Research Institute of the McGill University... and other collaborators

Recruiting

Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors (Lymfit_RCT)

Lymphoma | Cancer Survivors

Canada
Toronto Sunnybrook Regional Cancer Centre

Unknown

Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma

Lymphoma

Canada
AHS Cancer Control Alberta

Unknown

A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy

Anal Canal Cancer

Canada
AHS Cancer Control Alberta
Tom Baker Cancer Centre

Terminated

GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma (GEMHDM2014)

Follicular Lymphoma | Hodgkin's Lymphoma - Relapsed/Refractory | Non-Hodgkin's Lymphoma - Aggressive

Canada
British Columbia Cancer Agency

Approved for marketing

18F-FDG PET Imaging in Cardiac Sarcoidosis

Cardiac Sarcoidosis

Canada
The Ottawa Hospital

Withdrawn

Evaluation of a Novel Axillary Lymph Node Ink Localization Technique: A Feasibility Study

Breast Cancer | Axillary Lymphadenitis

Canada
University Health Network, Toronto

Completed

Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Canada
University Health Network, Toronto

Recruiting

Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis

Suspected Sarcoidosis

Canada
University Health Network, Toronto

Completed

Multi-Parametric Assessment of Breast Lymphedema

Breast Cancer | Breast Lymphedema

Canada
McMaster University
Holistic Health Research Foundation of Canada; Canadian Interdisciplinary Network...

Withdrawn

Acupuncture for Lymphedema Secondary to Breast Cancer Treatment

Lymphedema

Canada
University of Alberta

Completed

Using Telephone Counselling to Improve Exercise Participation in Hematologic Cancer Survivors

Lymphoma | Lymphoma, Non-Hodgkin | Leukemia | Behavior, Health

Canada
Western University, Canada

Completed

Capillary Versus Suction Needle Aspiration for Endobronchial Ultrasound (EBUS) Biopsies. (CAPSUNN-EBUS)

Lung Cancer | Thoracic Cancer | Mediastinal Lymphadenopathy

Canada
AHS Cancer Control Alberta

Withdrawn

Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL

Lymphoma

Canada
Sunnybrook Health Sciences Centre
Queen's University; The Leukemia and Lymphoma Society

Recruiting

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

Lymphoma | Chemotherapeutic Toxicity

Canada
Canadian Cancer Trials Group
AbbVie; Roche Pharma AG; Incyte Corporation

Recruiting

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Lymphoma, B-Cell

Canada
McGill University Health Centre/Research Institute...
Jewish General Hospital

Completed

Effect of Early Compression and Exercise on Lymphedema Incidence in Patients With Gynecological Cancer

Genital Neoplasms, Female | Lymphedema

Canada
Alaunos Therapeutics

Unknown

Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas

Advanced Solid Tumors | Lymphomas

Canada
University of Calgary

Completed

Endobronchial Ultrasonography in the Diagnosis of Sarcoidosis

Sarcoidosis | Mediastinal Diseases

Canada
Omnitura Therapeutics, Inc.

Completed

A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas

Neoplasms

Canada
University Health Network, Toronto

Recruiting

PET MRI Study in Patients With Cardiac Sarcoidosis

Sarcoidosis | Inflammatory Cardiomyopathy

Canada
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin

Canada
University Health Network, Toronto
CSL Behring

Completed

Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients (ScIGalloHCT)

Hypogammaglobulinemia

Canada
Sunnybrook Health Sciences Centre

Completed

Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon

Lymphoma, Follicular

Canada
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer

Breast Neoplasms | Lymphedema

Canada
Alberta Health Services, Calgary
University of Calgary; Tom Baker Cancer Centre

Not yet recruiting

Prophylactic LYMphatic Reconstruction (LYMbR) to Prevent Lymphedema After Node Dissection for Cutaneous Malignancies (LYMbR)

Lymphedema of Limb | Malignant Skin Neoplasm

Canada
Alberta Health services

Completed

HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

Low Grade Lymphoma

Canada
Centre hospitalier de l'Université de Montréal...

Recruiting

Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma

Lymphoma | Sarcoidosis | Adenopathy Hilar

Canada
Ottawa Regional Cancer Centre

Unknown

Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy

Lymphoma

Canada
University of Alberta
Alberta Cancer Foundation; Canadian Cancer Trials Group

Recruiting

Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) (ACIT001/EXC002)

Relapsed Non Hodgkin Lymphoma | Relapsed Pediatric ALL | Relapsed Adult ALL

Canada
University of British Columbia

Completed

Reliability and Validity of Self-measured Arm Circumference in Women With Breast Cancer

Breast Cancer | Lymphedema

Canada
McGill University
McGill University Health Centre/Research Institute of the McGill University...

Unknown

Study Combining Zevalin With High-Dose Chemotherapy Prior to Autologous StemCell Transplant in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's Lymphoma (Zevalin)

Non-Hodgkin's Lymphoma

Canada
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma

Lymphoma, Non-Hodgkin | Hodgkin's Disease

Canada
University Health Network, Toronto

Recruiting

R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma

Stage II Testicular Seminoma | Lymphadenopathy Retroperitoneal

Canada
Mirati Therapeutics Inc.

Completed

Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Non Hodgkin's Lymphoma | Tumors

Canada, United States
Ciusss de L'Est de l'Île de Montréal

Recruiting

Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01)

EBV Associated Lymphoma

Canada
Alberta Health Services, Calgary

Unknown

Development of a Tissue-Based & Cell Free DNA Next-Generation Sequencing Workflow

Non-Hodgkin Lymphoma

Canada
Sunnybrook Health Sciences Centre

Completed

Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon

Follicular Lymphoma

Canada
Sunnybrook Health Sciences Centre

Recruiting

A Phase II Trial of Intermediate Radiation Dose For Lymphoma

Follicular Lymphoma

Canada
Sunnybrook Health Sciences Centre

Completed

Y90 Ibritumomab Tiuxetan Post R-CHOP Chemotherapy for Advanced Stage Follicular Lymphoma (ZEVISS)

Follicular Lymphoma

Canada
Maisonneuve-Rosemont Hospital
Bayer

Unknown

Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma

Non-Hodgkins Lymphoma

Canada
Stephen Couban
Genzyme, a Sanofi Company

Completed

Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor

Malignant Lymphoma, Stem Cell Type

Canada
University Health Network, Toronto

Recruiting

Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma

Classical Hodgkin Lymphoma | Relapsed Cancer | Refractory Cancer

Canada
The Hospital for Sick Children

Completed

A Single-patient Clinical Trial of MAS825 in a Patient With XIAP Deficiency

X-linked Lymphoproliferative Syndrome Type 2 (XLP-2)

Canada
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

Low Dose Chest Computed Tomography (CT) Screening

Hodgkin's Lymphoma

Canada

Clinical Trials on Manual Lymphatic Drainage in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations